Dream. Develop.
Deliver.

Commitment to development, manufacturing and commercialization of drugs

Who we are

Dexcel Pharma is a privately owned pharmaceutical company developing, manufacturing, and commercializing innovative and generic products worldwide.
Where others see obstacles, we see opportunities

About us
blue arrow points to the right

Our products

Dexcel offers a diversified portfolio of pharmaceutical products

Read more
blue arrow points to the right
blue and white pill

Branded Rx

Innovative drugs across
therapeutic areas

yellow pill

OTC

National brands and private label pharmaceuticals

white pill

Generics

Broad portfolio of established,
niche, and first-to-market drugs in various dosage forms

Branded Rx

Innovative drugs across therapeutic areas

blue arrow points to the left

OTC

blue arrow points to the right

National brands and private-label pharmaceuticals

Generics

Broad portfolio of established, niche, and first-to-market drugs in various dosage forms

blue arrow points to the left
blue and white pillyellow pillwhite pill

Innovation

We are committed to investing in the R&D and commercialization of novel drugs and technologies. We dedicate resources to internal and external innovation in small molecules, biologics, oligonucleotides, and genetic medicine across therapeutic areas

Discover more
white arrow points to the right

Markets

Dexcel commercializes branded and generic pharmaceutical products globally via a network of affiliates, distributors, and partners. We recognize market-specific needs and quickly identify local opportunities. Our key markets are the United States, Israel, Germany, the United Kingdom, and Austria.

Global reach
blue arrow points to the right